Transcatheter Heart Valve Replacement Market Size, Share, Trends, Growth 2030

Transcatheter Heart Valve Replacement Market

Transcatheter Heart Valve Replacement Market By Product Type [Transcatheter Pulmonary Valve Replacement, Transcatheter Mitral Valve Repair & Replacement, and Transcatheter Aortic Valve Replacement], By Surgical Approach [Transapical Approach, Transfemoral Approach, and Others], By End-User [Cath Labs and Hospitals], By Application [Pulmonary Valvular Heart Disease, Mitral Valvular Heart Disease, and Aortic Valvular Heart Disease], By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030

Category: Technology & Media Report Format : PDF Report Code: ZMR-5727 Status : Upcoming
Market Size in 2022 Market Forecast in 2030 CAGR (in %) Base Year
USD 5.65 Billion USD 10.48 Billion 7.97% 2022

Transcatheter Heart Valve Replacement Market

Description

The global transcatheter heart valve replacement market size was worth around USD 5.65 billion in 2022 and is predicted to grow to around USD 10.48 billion by 2030 with a compound annual growth rate (CAGR) of roughly 7.97% between 2023 and 2030.

Transcatheter Heart Valve Replacement Market SizeRequest Free Sample

The report analyzes the global growler market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the transcatheter heart valve replacement industry.           

Global Transcatheter Heart Valve Replacement Market: Overview

Transcatheter aortic valve replacement (TAVR) is a minimally invasive method to replace a damaged and old valve. TAVR is also known as transcatheter aortic valve implantation (TAVI). Transcatheter aortic valve replacement (TAVR) is the procedure for people who have a high or immediate risk of complications from open-heart surgery. It aids patients to get relief from aortic valve stenosis. Aortic valve stenosis happens when the aortic valve of the heart calcifies and thickens. It protects the valve from opening to its full width and limits the flow of blood from the heart to the rest of the body. The aortic valve stenosis causes fainting, chest pain, leg pain, fatigue, and shortness of breath. It can also result in a sudden cardiac attack and heart failure.

Global Transcatheter Heart Valve Replacement Market: Growth Factors

The increasing number of patients suffering from several cardiovascular diseases like coronary artery diseases, heart failure, hypertension, and many others is one of the major reasons driving the growth of the global transcatheter heart valve replacement market. Cardiovascular diseases cause improper functioning of aortic valves. Hence it boosts the demand for efficient procedures for valve replacements. The growing investments in the healthcare sector to strengthen the medical system are boosting the growth of the global transcatheter heart valve replacement market. The technological advancements and developments in the transcatheter aortic valve replacement procedure are anticipated to bolster the market growth globally.

Furthermore, the growing adoption of minimal invasive surgery to reduce the time duration of hospital stay and healthcare expenditure is projected to fuel the growth of the global market. The constantly growing geriatric population coupled with the increasing incidences of heart valve diseases is fostering the market to grow significantly during the forecast period. The manufacturers of advanced devices are emphasizing extensive research and development activities to develop more modern and minimal invasive methods to treat the patients is positively shaping the trajectory of the global transcatheter heart valve replacement market during the forecast period.

Transcatheter Heart Valve Replacement Market: Report Scope

Report Attributes Report Details
Report Name Transcatheter Heart Valve Replacement Market Research Report
Market Size in 2022 USD 5.65 Billion
Market Forecast in 2030 USD 10.48 Billion
Growth Rate CAGR of 7.97%
Number of Pages 210
Key Companies Covered Braile Biomedica, Edwards Lifesciences Corporation, Cook Medical Inc., JC Medical, Inc., Venus Medtech, Inc., Medtronic, plc, NVT AG, Boston Scientific Corporation, JenaValve Technology, Inc., Abbott Laboratories Inc., Bracco S.p.A. (HLT, Inc.), Meril Life Sciences Pvt. Ltd., and St. Jude Medical, Inc
Segments Covered By Product, By Surgical Approach, By Application, By End-User, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2022
Historical Year 2017 to 2021
Forecast Year 2023 - 2030
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Transcatheter Heart Valve Replacement Market: Segmentation

The global transcatheter heart valve replacement market can be segmented into application, surgical approach, product, end-use, and region.

By Application, the market can be segmented into pulmonary valvular heart disease, mitral valvular heart disease, and aortic valvular heart disease.

By Surgical Approach, the market can be segmented into the transapical approach, transfemoral approach, and others. The transapical approach segment holds hegemony over others due to the provision of convenient wiring with outstanding controllability and antegrade approach. It aids in quick accessibility to the aortic valve easily and hence the approach is used on large scale in transcatheter aortic valve implementation. Moreover, the approach maintains close proximity to identify, target, and control implantation.

By Product, the market can be segmented into transcatheter pulmonary valve replacement, transcatheter mitral valve repair & replacement, and transcatheter aortic valve replacement. The transcatheter mitral valve repair & replacement segment dominates the market over others.

By End-Use, the market can be segmented into cath labs and hospitals. The hospital segment accounts for the largest share in the global transcatheter heart valve replacement market owing to the reimbursement done by the hospital. Furthermore, the presence of a professional surgeon in the hospital and advanced tools utilized in the procedure is projecting the growth of the segment.

Global Transcatheter Heart Valve Replacement Market: Competitive Players

Some of the significant players in the global transcatheter heart valve replacement market are Braile Biomedica, Edwards Lifesciences Corporation, Cook Medical Inc., JC Medical, Inc., Venus Medtech, Inc., Medtronic, plc, NVT AG, Boston Scientific Corporation, JenaValve Technology, Inc., Abbott Laboratories Inc., Bracco S.p.A. (HLT, Inc.), Meril Life Sciences Pvt. Ltd., and St. Jude Medical, Inc.

Global Transcatheter Heart Valve Replacement Market: Regional Analysis

North America holds the largest share in the global transcatheter heart valve replacement market due to the growing incidences of heart valve disorders in the region. The favorable reimbursement procedures by the medicare centers are also fueling the growth of the regional market growth.

Global Transcatheter Heart Valve Replacement Market SizeRequest Free Sample

Europe is anticipated to witness huge growth during the forecast period owing to the growing technological advancements and surging incidences of cardiovascular diseases.

Transcatheter Heart Valve Replacement Market: Competitive Analysis

The global transcatheter heart valve replacement market is dominated by players like:

  • Braile Biomedica
  • Edwards Lifesciences Corporation
  • Cook Medical Inc
  • JC Medical, Inc
  • Venus Medtech Inc
  • Medtronic plc
  • NVT AG
  • Boston Scientific Corporation
  • JenaValve Technology, Inc
  • Abbott Laboratories Inc
  • Bracco S.p.A. (HLT, Inc.)
  • Meril Life Sciences Pvt Ltd
  • St. Jude Medical, Inc

Global Transcatheter Heart Valve Replacement Market: Segment Analysis

By Product

  • Transcatheter Pulmonary Valve Replacement
  • Transcatheter Mitral Valve Repair & Replacement
  • Transcatheter Aortic Valve Replacement

By Surgical Approach

  • Transapical Approach
  • Transfemoral Approach
  • Others

By End-Use

  • Cath Labs
  • Hospitals

By Application

  • Pulmonary Valvular Heart Disease
  • Mitral Valvular Heart Disease
  • Aortic Valvular Heart Disease

Global Transcatheter Heart Valve Replacement Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

  • zion payment modes

FrequentlyAsked Questions

Transcatheter aortic valve replacement (TAVR) is a minimally invasive method to replace a damaged and old valve.

The increasing number of patients suffering from several cardiovascular diseases like coronary artery diseases, heart failure, hypertension, and many others is one of the major reasons driving the growth of the global transcatheter heart valve replacement market.

The global transcatheter heart valve replacement market size was worth around USD 5.65 billion in 2022 and is predicted to grow to around USD 10.48 billion by 2030.

The global transcatheter heart valve replacement market is expected to grow at a CAGR of 7.97% during the forecast period.

North America holds the largest share in the global transcatheter heart valve replacement market due to the growing incidences of heart valve disorders in the region. The favorable reimbursement procedures by the medicare centers are also fueling the growth of the regional market growth.

Some of the significant players in the global transcatheter heart valve replacement market are Braile Biomedica, Edwards Lifesciences Corporation, Cook Medical Inc., JC Medical, Inc., Venus Medtech, Inc., Medtronic, plc, NVT AG, Boston Scientific Corporation, JenaValve Technology, Inc., Abbott Laboratories Inc., Bracco S.p.A. (HLT, Inc.), Meril Life Sciences Pvt. Ltd., and St. Jude Medical, Inc.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed